Macrophages in immunoregulation and therapeutics

S Chen, AFUH Saeed, Q Liu, Q Jiang, H Xu… - … and Targeted Therapy, 2023 - nature.com
Macrophages exist in various tissues, several body cavities, and around mucosal surfaces
and are a vital part of the innate immune system for host defense against many pathogens …

[HTML][HTML] Role of miRNA and lncRNAs in organ fibrosis and aging

S Ghafouri-Fard, A Abak, SF Talebi, H Shoorei… - Biomedicine & …, 2021 - Elsevier
Fibrosis is the endpoint of pathological remodeling. This process contributes to the
pathogenesis of several chronic disorders and aging-associated organ damage. Different …

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

D Cheng, Q Xu, Y Wang, G Li, W Sun, D Ma… - Journal of translational …, 2021 - Springer
Background Silicosis is one of the most common occupational pulmonary fibrosis caused by
respirable silica-based particle exposure, with no ideal drugs at present. Metformin, a …

Insights into biological role of LncRNAs in epithelial-mesenchymal transition

JT Cheng, L Wang, H Wang, FR Tang, WQ Cai, G Sethi… - Cells, 2019 - mdpi.com
Long non-coding RNAs (lncRNAs) are versatile regulators of gene expression and play
crucial roles in diverse biological processes. Epithelial-mesenchymal transition (EMT) is a …

LncRNA: Shedding light on mechanisms and opportunities in fibrosis and aging

Z Yang, S Jiang, J Shang, Y Jiang, Y Dai, B Xu… - Ageing research …, 2019 - Elsevier
Fibrosis is universally observed in multiple aging-related diseases and progressions and is
characterized by excess accumulation of the extracellular matrix. Fibrosis occurs in various …

Novel drug delivery systems and disease models for pulmonary fibrosis

R Li, Y Jia, X Kong, Y Nie, Y Deng, Y Liu - Journal of Controlled Release, 2022 - Elsevier
Pulmonary fibrosis (PF) is a serious and progressive lung disease which is possibly life-
threatening. It causes lung scarring and affects lung functions including epithelial cell injury …

ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1

W Sun, Y Li, D Ma, Y Liu, Q Xu, D Cheng, G Li… - Cellular & molecular …, 2022 - Springer
Abstract Background N 6-methyladenosine (m6A) is the most common and abundant
internal modification of RNA. Its critical functions in multiple physiological and pathological …

MiR-326 inhibits inflammation and promotes autophagy in silica-induced pulmonary fibrosis through targeting TNFSF14 and PTBP1

T Xu, W Yan, Q Wu, Q Xu, J Yuan, Y Li… - Chemical Research …, 2019 - ACS Publications
Silicosis is a kind of irreversible pulmonary fibrosis induced by the long-term inhalation of
silica particles. The therapeutic strategy based on the microRNAs might be an effective way …

New aspects of the epigenetic regulation of EMT related to pulmonary fibrosis

XC Wang, K Song, B Tu, H Sun, Y Zhou, SS Xu… - European Journal of …, 2023 - Elsevier
Pulmonary fibrosis is a chronic and progressive fibrotic disease that results in impaired gas
exchange, ventilation, and eventual death. The pro-fibrotic environment is instigated by …

lncRNA PFAR promotes lung fibroblast activation and fibrosis by targeting miR-138 to regulate the YAP1-twist axis

X Zhao, J Sun, Y Chen, W Su, H Shan, Y Li, Y Wang… - Molecular Therapy, 2018 - cell.com
Long non-coding RNAs (lncRNAs) have been reported to be involved in various
pathophysiological processes in many diseases. However, the role and mechanism of …